Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies.

ABSTRACT:

SUBMITTER: Hu J 

PROVIDER: S-EPMC7905196 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature